Dechra Pharmaceuticals' purchase of Elanco's Osurnia business probed in UK
MLex Summary: Dechra Pharmaceuticals' planned acquisition of Elanco Animal Health's Osurnia business is being probed by the UK Competition and Markets Authority. Dechra, which makes veterinary pharmaceutical products, agreed to purchase...To view the full article, register now.
Already a subscriber? Click here to view full article